Matthew Gianferante, M.D., M.P.H.

Biography

Matthew Gianferante, M.D., M.P.H., joined the Clinical Genetics Branch (CGB) as a postdoctoral clinical fellow in 2017 and was appointed as a staff clinician in 2022. Dr. Gianferante obtained his M.D. at the Uniformed Services University of the Health Sciences (USUHS), Bethesda, Maryland. He completed a pediatric residency at Tufts Floating Hospital for Children, Boston, Massachusetts, a pediatric hematology oncology fellowship at Walter Reed National Military Medical Center, Bethesda, Maryland, and a master’s in public health with a concentration in epidemiology and biostatistics from USUHS. In 2022, he received an NIH Director's Award as part of the NIH COVID Vaccine and Booster Clinic Team.

Research Interests

Dr. Gianferante works with Lisa Mirabello, Ph.D., to study the germline genetics of osteosarcoma and non-rhabdomyosarcoma. He also focuses on gene discovery and genotype-phenotype characterization of Diamond Blackfan anemia patients in the inherited bone marrow failure cohort with Sharon Savage, M.D., Chief and senior investigator, and Neelam Giri, M.D., staff clinician. Dr. Gianferante is a commissioned officer in the United States Public Health Service (USPHS) and has been deployed numerous times for medical missions since 2017. He received the USPHS Uniformed Services Chapter East Outstanding Young Pediatrician award in 2021.